Leslie V Norwalk
Director at Globus Medical Inc (GMED); Director at Neurocrine Biosciences Inc (NBIX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 30SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 1,2501,588 held (−44%) | $182.01 | $228K | -21.7% |
| Jun 8SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 1,2502,838 held (−31%) | $168.06 | $210K | -15.2% |
| May 14SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 3,8102,429 held (−61%) | $155.01 | $591K | -8.1% |
| Jan 12SEC | GMEDGlobus Medical Inc | Sell Plan | 2,00010,419 held (−16%) | $101.10 | $202K | -26.2% |
| Dec 17SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 5,0007,429 held (−40%) | $152.23 | $761K | -6.4% |
| Dec 17SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 1,1906,239 held (−16%) | $155.09 | $185K | -8.2% |
| Dec 16SEC | GMEDGlobus Medical Inc | Sell Plan | 4,00012,419 held (−24%) | $88.85 | $355K | -16.0% |
- Sell
Director Leslie V Norwalk sold $228K of NBIX at $182.01 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Leslie V Norwalk sold $210K of NBIX at $168.06 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Leslie V Norwalk sold $591K of NBIX at $155.01 — cuts the stake by 61%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Leslie V Norwalk sold $202K of GMED at $101.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Leslie V Norwalk sold $761K of NBIX at $152.23 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Leslie V Norwalk sold $185K of NBIX at $155.09 — pre-scheduled 10b5-1 plan sale.